Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Crescendo Aims To Increase IO Share Of Voice With Humabody Platform

Executive Summary

The Immuno-oncology space is a crowded and consequently represents a big challenge for small biotechs to get share of voice. Crescendo Biologics CEO Peter Pack took time off from his busy partnering schedule at BIO-Europe Spring 2018 to outline to Scrip how the company's Humabody platform is being used to develop both in-house and partnered opportunities.







Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts